Literature DB >> 16413978

Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release.

Yasser El-Malah1, Sami Nazzal.   

Abstract

The aim of the present study was to screen the effect of seven factors--POLYOX molecular weight (X(1)) and amount (X(2)); carbopol (X(3)), lactose (X(4)), sodium chloride (X(5)), citric acid (X(6)); compression pressure (X(7))--on (1) the release of theophylline from hydrophilic matrices, demonstrated by changes in dissolution rate, and (2) their impact on the release exponent [n] indicative of the drug transport mechanism through the diffusion matrix. This objective was accomplished utilizing the Placket-Burman screening design. Theophylline tablets were prepared according to a 7-factor-12-run statistical model and subjected to a 24-h dissolution study in phosphate buffer at pH 7.2. The primary response variable, Y(4), was the cumulative percent of theophylline dissolved in 12h. The regression equation for the response was Y(4)=66.2167 - 17.5833X(1) - 3.3833X(2) - 9.366X(3) - 1.1166X(4) - 0.6166X(5) + 2.6X(6) - 2.783X(7). This polynomial model was validated by the ANOVA and residual analysis. The results showed that only two factors (X(2) and X(3)) had significant effect (p-value<0.10) on theophylline release from the hydrophilic polymer matrix. Factors (X(2) and X(7)) had significant effect (p-value<0.10) on [n], the exponent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413978     DOI: 10.1016/j.ijpharm.2005.11.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Use of Placket-Burman statistical design to study effect of formulation variables on the release of drug from hot melt sustained release extrudates.

Authors:  Satishkumar P Jain; Pirthi Pal Singh; Sharad Javeer; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2010-05-28       Impact factor: 3.246

2.  Spectral and spatial characterization of protein loaded PLGA nanoparticles.

Authors:  Ahmed S Zidan; Ziyaur Rahman; Muhammad J Habib; Mansoor A Khan
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

3.  Preparation and evaluation of poly (caprolactone fumarate) nanoparticles containing doxorubicin HCI.

Authors:  N Shokri; H Akbari Javar; Sh Fouladdel; A Khalaj; Mr Khoshayand; R Dinarvand; F Atyabi; A Nomani; E Azizi
Journal:  Daru       Date:  2011       Impact factor: 3.117

4.  Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac.

Authors:  Bin Huang; Wei-Jiang Dong; Gao-Yi Yang; Wei Wang; Cong-Hua Ji; Fei-Ni Zhou
Journal:  Drug Des Devel Ther       Date:  2015-07-23       Impact factor: 4.162

5.  Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.

Authors:  Yi-Dan Chen; Zhong-Yuan Liang; Yan-Yan Cen; He Zhang; Mei-Gui Han; Yun-Qiao Tian; Jie Zhang; Shu-Jun Li; Da-Sheng Yang
Journal:  Drug Des Devel Ther       Date:  2015-11-20       Impact factor: 4.162

6.  Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.

Authors:  Saeed Shojaee; Ali Nokhodchi; Mohammed Maniruzzaman
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 5.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.